Estados Unidos · Plataformas y datos · MarketBeat

Dr. Reddy's Laboratories Ltd (NYSE:RDY) Stock Has Consensus Target Price of $492.90

Publicado por MarketBeat · Estados Unidos hace 1 h

Dr. Reddy's Laboratories Ltd (NYSE:RDY - Get Free Report) has earned an average recommendation of "Hold" from the five analysts that are presently covering the firm, Marketbeat…

Leer el artículo completo en MarketBeat Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.marketbeat.com)

Dr. Reddy's Laboratories Ltd (NYSE:RDY) Stock Has Consensus Target Price of $492.90

También te puede interesar

Down 17%, Is Meta a Buy on the Dip?

Johnson & Johnson reports response rate for head, neck cancer treatment

Goldman lists 3 factors that support long commodities positions

‘She’s living the dream’: My stepmother said I can buy my childhood home for $850,000. Is she taking advantage of me?

Samsung’s Galaxy Fit 4 could undercut Fitbit by $120

TeraWulf CEO Paul Prager Turns Elon Musk’s ‘Stranded Compute’ Warning Into A Buying Pitch

Dr. Reddy's Laboratories Ltd (NYSE:RDY) Stock Has Consensus Target Price of $492.90

Compartir

También te puede interesar

Down 17%, Is Meta a Buy on the Dip?

Johnson & Johnson reports response rate for head, neck cancer treatment

Goldman lists 3 factors that support long commodities positions

‘She’s living the dream’: My stepmother said I can buy my childhood home for $850,000. Is she taking advantage of me?

Samsung’s Galaxy Fit 4 could undercut Fitbit by $120

TeraWulf CEO Paul Prager Turns Elon Musk’s ‘Stranded Compute’ Warning Into A Buying Pitch